Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDI inhibitors(protein disulfide isomerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H10N2O4S3 |
InChIKeySPYIETQLOVDJCF-UHFFFAOYSA-N |
CAS Registry346640-08-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Discovery | CN | 21 Feb 2024 |